XM does not provide services to residents of the United States of America.

Altria posts lower-than-expected quarterly results on muted cigarette demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Altria posts lower-than-expected quarterly results on muted cigarette demand</title></head><body>

July 31 (Reuters) -Altria MO.N missed expectations for quarterly revenue and profit on Wednesday, as the tobacco giant contends with persistent weakness in demand for its cigarette brands.

Shares of the company, which have risen 25% so far this year, were down 2% in premarket trade.

The Marlboro maker, similar to other tobacco peers, has bet heavily on smoking alternatives as stricter regulation and awareness of health risks have dented demand for traditional cigarettes in some markets.

Total shipments of cigarettes fell 13% in the second quarter as demand for its more expensive brands came under pressure, with cash-strapped consumers looking towards cheaper alternatives or vapes.

Altria also said promotions on its brands had hurt revenue.

The company's adjusted earnings per share of $1.31 fell short of estimates of $1.35, as per LSEG data.

Quarterly revenue, net of excise taxes, fell 3% to $5.28 billion, missing estimates of $5.39 billion.

The company's menthol flavored NJOY vape products became the first flavored vapes to get sale authorization from the U.S. Food and Drug Administration last month.

Reported shipment volume for NJOY devices rose 80% sequentially in the reported quarter ended June 30.

The U.S. regulator has rejected a vast majority of the 26 million applications it has reviewed so far, including from British American Tobacco BATS.L, and all of those relating to flavored products.

Still, Altria has had to tackle stiff competition from cheaper disposable alternatives in the vapes category.

In the oral tobacco category, it has dealt with several quarters of weakness in dipping tobacco products such as Copenhagen.

Shipment volume for on! nicotine pouches, however, grew 37.3% compared with a year earlier, following a 32% rise in the preceding quarter.

Altria tightened its forecast for annual profit per share to between $5.07 and $5.15, compared with an earlier target of $5.05 to $5.17.



Reporting by Juveria Tabassum and Emma Rumney; Editing by Krishna Chandra Eluri

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.